Analysis of Myc-target gene, Mina53 in cells and in a body

细胞和体内 Myc 靶基因 Mina53 的分析

基本信息

  • 批准号:
    16570164
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Mina53 is a nuclear protein, which has a domain called JmjC. When the effect of Mina53 over-expression on activity of various promoters, it was found that Mina53 stimulates E2F site dependent promoter activity. Since E2F is a transcription factor, which highly influences cell proliferations, the activity of Mina53 to stimulate the E2F site dependent promoter activity appears to be involved in the control of cell proliferation by Mina53. In 2006, it was reported that JmjC domain is related to Histone demethylase activity. Then it becomes an important next question if Mina53 has the enzyme activity.We produced antibody that recognized mouse Mina53 protein, and then investigate expression pattern of Mina53 in a mouse body. It was observed the high expression of Mina53 in testis, spleen, colon, where cells are proliferating well. When we investigated the expression pattern of Mina53 in testis in detail, it was found that Mina53 is highly expressed in spermatogonia, especially in type A spe … More rmatogonia.These results suggest that Mina53 is related to cell proliferation not only in cancer but also in normal tissues.2,Myc-target genes can be classified into two classesWe cloned another Myc-target gene mimitin by the similar methods for mina53 cloning. Mimitin was found to encode Mitochondrial protein and involved in cell proliferation of esophageal squamous cell carcinoma cells. Mina53 and Mimitin are highly expressed in some human cancer tissues, and they are required for cell proliferation in some types of cells. However, it appears some types of cells do not require them for cell proliferation. These may be due to the existence of a functionally redundant protein and/or mechanism. These Myc-target genes can be classified into one group as "specufuc type". On the other hand, there are Myc-responsive genes, which appear to be generally important for all types of cells to proliferate. Inhibition of the function of one of the specific type of Myc-responsive genes may hamper only some restricted types of cells and would have fewer side effects and more potential than a general type for cancer therapy. Less
Mina 53是一种核蛋白,其具有称为JmjC的结构域。当研究Mina 53过表达对各种启动子活性的影响时,发现Mina 53刺激E2 F位点依赖性启动子活性。由于E2 F是高度影响细胞增殖的转录因子,Mina 53刺激E2 F位点依赖性启动子活性的活性似乎参与Mina 53对细胞增殖的控制。2006年有报道称JmjC结构域与组蛋白去甲基化酶活性有关。因此,Mina 53是否具有酶活性成为下一个重要的问题。我们制备了识别小鼠Mina 53蛋白的抗体,然后研究了Mina 53在小鼠体内的表达模式。在睾丸、脾脏、结肠中观察到Mina 53的高表达,这些细胞增殖良好。我们详细研究了Mina 53在睾丸中的表达模式,发现Mina 53在精原细胞中高表达,特别是在A型精子中, ...更多信息 2、Myc靶基因可分为两类我们用与mina 53相似的方法克隆了另一个Myc靶基因mimitin。Mimitin编码线粒体蛋白,参与食管鳞癌细胞增殖。Mina 53和Mimitin在某些人类癌症组织中高度表达,并且它们是某些类型细胞中细胞增殖所需的。然而,似乎某些类型的细胞不需要它们进行细胞增殖。这可能是由于存在功能冗余的蛋白质和/或机制。这些Myc靶基因可以被分类为一组“特异性类型”。另一方面,有Myc反应基因,这似乎是所有类型的细胞增殖一般重要。抑制一种特定类型的Myc反应基因的功能可能只会阻碍某些有限类型的细胞,并且比一般类型的癌症治疗具有更少的副作用和更大的潜力。少

项目成果

期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
大腸癌における新規Myc標的遺伝子mina53の発現
新型Myc靶基因mina53在结直肠癌中的表达
Myc標的遺伝子mimitin
Myc 靶基因 mimitin
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Haptoglobin Gene Promoter Polymorphism and Haplotypes are unique in Different Populations
触珠蛋白基因启动子多态性和单倍型在不同人群中是独特的
A novel 1247T missense mutation in the haptoglobin 2 β chain decreases the protein expression and associates with ahaptoglobinemia.
触珠蛋白 2 β 链中的一个新的 1247T 错义突变会降低蛋白质表达并与触珠蛋白血症相关。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Teye;K. et al.
  • 通讯作者:
    K. et al.
GIP stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3-K)/ protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxol and downregulation of bax expression
GIP 对胰腺 β 细胞存活的刺激依赖于磷脂酰肌醇 3 激酶 (PI3-K)/蛋白激酶 B (PKB) 信号传导、叉头转录因子 Foxol 的失活以及 bax 表达的下调
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSUNEOKA Makoto其他文献

TSUNEOKA Makoto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TSUNEOKA Makoto', 18)}}的其他基金

Ablation of Mina53 in mice reduces allergic response in the airways
小鼠中 Mina53 的消融可减少呼吸道过敏反应
  • 批准号:
    21570204
  • 财政年份:
    2009
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Functions and Domains of A Novel Cell Proliferation Relating Protein Meu-2
新型细胞增殖相关蛋白Meu-2的功能和结构域分析
  • 批准号:
    14580705
  • 财政年份:
    2002
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies of the mechanism for anchorage independent growth induced by c-myc
c-myc诱导贴壁独立生长机制的研究
  • 批准号:
    10680678
  • 财政年份:
    1998
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
  • 批准号:
    81673007
  • 批准年份:
    2016
  • 资助金额:
    54.0 万元
  • 项目类别:
    面上项目

相似海外基金

Point-of-Care Diagnosis of Esophageal Cancer in LMICs
中低收入国家食管癌的即时诊断
  • 批准号:
    10649166
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Clinical impact of Leucine-Rich alpha-2 Glycoprotein in patients with esophageal cancer
富含亮氨酸的 α-2 糖蛋白对食管癌患者的临床影响
  • 批准号:
    23K15487
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Basic research for macrophage immune check point inhibition as a novel esophageal cancer therapy
巨噬细胞免疫检查点抑制作为食管癌新型疗法的基础研究
  • 批准号:
    23K15525
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Depletion of tumor suppressor miRNAs in blood relates to tumor progression and poor outcomes in esophageal cancer
血液中抑癌 miRNA 的消耗与食管癌的肿瘤进展和不良预后相关
  • 批准号:
    23K06700
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Overcoming the drug resistance through drug repositioning in esophageal cancer
通过药物重新定位克服食管癌耐药性
  • 批准号:
    23K08221
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a Postoperative Patient Support System for Esophageal Cancer Using Metaverse
使用 Metaverse 开发食管癌术后患者支持系统
  • 批准号:
    23H03197
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of retroviral replicating vector-mediated liver-expressed iron-regulating peptide hormone, hepcidine gene therapy for esophageal cancer.
开发逆转录病毒复制载体介导的肝脏表达的铁调节肽激素、食道癌的铁碱基因疗法。
  • 批准号:
    23K08184
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of tumor microbiome and mechanism of malignant transformation in esophageal cancer
食管癌肿瘤微生物组及恶变机制分析
  • 批准号:
    23K08129
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of tight junction in metastasis of esophageal cancer
紧密连接在食管癌转移中的作用
  • 批准号:
    23K14593
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer
HORMAD 特异性 TGF-β 耐药性记忆 T 细胞用于治疗胃食管癌患者
  • 批准号:
    10731407
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了